Showing results (61-70 of 148) with videos related to
Sort By:
Pageof 15
Respiratory Research|December 15, 2018
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Helgo Magnussen, et al.Current Neuropharmacology|December 31, 2020
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative StressGanesh Raghu, Michael Berk, Peter A Campochiaro, et al.Respiratory Medicine|January 31, 2014
Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationaleHelgo Magnussen, Henrik Watz, Anne Kirsten, et al.The New England Journal of Medicine|February 23, 2007
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseasePeter M A Calverley, Julie A Anderson, Bartolome Celli, et al.Lancet (London, England)|September 1, 2009
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsLeonardo M Fabbri, Peter M A Calverley, José Luis Izquierdo-Alonso, et al.Respiratory Research|August 11, 2017
A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary diseasePeter M A Calverley, Sanjay Sethi, Michelle Dawson, et al.Chest|June 26, 2010
Reported pneumonia in patients with COPD: findings from the INSPIRE studyPeter M A Calverley, Robert A Stockley, Terence A R Seemungal, et al.Annals of the American Thoracic Society|August 18, 2021
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFTNirupama Putcha, Antonio R Anzueto, Peter M A Calverley, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 29, 2022
The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE DatasetPeter M A Calverley, Alberto Papi, Clive Page, et al.Advances in Therapy|August 11, 2020
Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® TrialsJadwiga A Wedzicha, Roland Buhl, Dave Singh, et al.Pageof 15